| Report ID | 279748 |
| Drug Identification Number | 02139499 |
| Brand name | MAGNESIUM SULFATE INJECTION, USP |
| Common or Proper name | MAGNESIUM SULFATE INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | MAGNESIUM SULFATE |
| Strength(s) | 500MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 10mL |
| ATC code | B05XA |
| ATC description | I.V. SOLUTION ADDITIVES |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2026-03-01 |
| Actual start date | |
| Estimated end date | 2026-04-01 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2026-03-05 |
| Company comments | Product is on allocation at 50% |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-03-05 | French | Compare |
| v1 | 2026-03-05 | English | Compare |
Showing 1 to 2 of 2